Company: HURA
Filing Date: 2025-05-23
Form Type: 424B3
Source: 0001193125-25-125499
Chunk: 794

Company: TuHURA Biosciences, Inc./NV
Filing Date: 2025-05-23
Form: 424B3
Chunk 794
---
2023 
    (in thousands) |
|:-------------------|:---------------|:----|------------------:|:----|:----|------------------:|:----|:----|------------------:|
| 4.66               |                |     |                79 |     |     |              9.67 |     |     |                 8 |
| 6.04               |                |     |                 9 |     |     |              9.14 |     |     |                 — |
| 8.79               |                |     |                39 |     |     |              7.63 |     |     |                16 |
| 12.75 to 16.25     |                |     |                 6 |     |     |              8.78 |     |     |                 6 |
| 30.50 to 48.00     |                |     |                80 |     |     |              7.14 |     |     |                47 |
| 62.00 to 68.50     |                |     |                14 |     |     |              6.81 |     |     |                14 |
| 85.00              |                |     |                 9 |     |     |              5.43 |     |     |                 9 |
| 304.95 to 2,660.00 |                |     |                 1 |     |     |              2.33 |     |     |                 1 |
|                    |                |     |               237 |     |     |                   |     |     |               101 |

F-61

Kintara Therapeutics, Inc. Notes to Condensed Consolidated Interim Financial Statements (Unaudited) December 31, 2023 (expressed in US dollars and in thousands, except par value and per share amounts, unless otherwise noted) Stock options granted during the six months ended December 31, 2023, have been valued using a Black-Scholes pricing model with the following assumptions:

|                         |     | December 31, 2023 |       |   |
|:------------------------|:----|:------------------|------:|:--|
| Dividend rate           |     |                   |     — | % |
| Estimated volatility    |     |                   | 91.40 | % |
| Risk-free interest rate